Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients
High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer
Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline
Patch-Lozenge Combination Best For Smoking Cessation
Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma
Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer
Black-White Disparity Seen In End Of Life Treatment
HER2+ Tumors Increase Risk Of Recurrence, Study Finds
The Clinical Cancer Letter To End Print Edition In 2010
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
